Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신윤용 | * |
dc.contributor.author | 이화정 | * |
dc.contributor.author | 김대기 | * |
dc.date.accessioned | 2016-08-28T11:08:12Z | - |
dc.date.available | 2016-08-28T11:08:12Z | - |
dc.date.issued | 2014 | * |
dc.identifier.issn | 1520-4804 | * |
dc.identifier.other | OAK-11437 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/227840 | - |
dc.language | English | * |
dc.publisher | American Chemical Society | * |
dc.title | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent | * |
dc.type | Article | * |
dc.relation.issue | 10 | * |
dc.relation.volume | 57 | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 4213 | * |
dc.relation.lastpage | 4238 | * |
dc.relation.journaltitle | Journal of Medicinal Chemistry | * |
dc.identifier.doi | 10.1021/jm500115w | * |
dc.identifier.wosid | WOS:000336510100022 | * |
dc.identifier.scopusid | 2-s2.0-84901270358 | * |
dc.author.google | Jin C.H. | * |
dc.author.google | Krishnaiah M. | * |
dc.author.google | Sreenu D. | * |
dc.author.google | Subrahmanyam V.B. | * |
dc.author.google | Rao K.S. | * |
dc.author.google | Lee H.J. | * |
dc.author.google | Park S.-J. | * |
dc.author.google | Park H.-J. | * |
dc.author.google | Lee K. | * |
dc.author.google | Sheen Y.Y. | * |
dc.author.google | Kim D.-K. | * |
dc.contributor.scopusid | 신윤용(6603872711) | * |
dc.contributor.scopusid | 이화정(57102029300) | * |
dc.contributor.scopusid | 김대기(35083694200) | * |
dc.date.modifydate | 20240118154655 | * |